Boston-According to Chris Lievens, OD, MS, FNAP, FAAO, Vuity is the first eye drop approved for the treatment of presbyopia, and the middle distance visual acuity was significant during all 10 hours of testing a day improve.
The 1.25% pilocarpine eye drops from Abbvie's Allergan provides “patients with a new way to show vision improvement within the distance of working most of our working day,” Livings said at the National Academy of Sciences Optometry annual meeting. "For a drug that is very well tolerated and has few adverse events, this is really exciting."
Send the latest news and education to your inbox
© 2021 Healio All rights reserved.
Send the latest news and education to your inbox
© 2021 Healio All rights reserved.